Gene Therapy Deal-Making Trends, 2012-2017 Featuring Pfizer, Vertex, Biogen, Bamboo Therapeutics & Gilead … – Business Wire (press release)
|
Gene Therapy Deal-Making Trends, 2012-2017 Featuring Pfizer, Vertex, Biogen, Bamboo Therapeutics & Gilead …
Business Wire (press release) A robust deal-making market has enabled gene therapy drug development to be advanced and adequately funded through alliances and financings, and in many cases has provided exits for investors through acquisitions. The volume of deals in each of these … |
